Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment. | Mediators Inflamm | 2023 | 37181807 | PubTator, text mining | PubMed |
| Mitochondria: It is all about energy. | Front Physiol | 2023 | 37179826 | PubTator, text mining | PubMed |
| The Relationship between Insomnia and the Pathophysiology of Major Depressive Disorder: An Evaluation of a Broad Selection of Serum and Urine Biomarkers. | Int J Mol Sci | 2023 | 37176140 | PubTator, text mining | PubMed |
| Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia. | Int J Mol Sci | 2023 | 37175824 | PubTator, text mining | PubMed |
| Distinct Traits of Structural and Regulatory Evolutional Conservation of Human Genes with Specific Focus on Major Cancer Molecular Pathways. | Cells | 2023 | 37174700 | PubTator, text mining | PubMed |
| UVRAG Promotes Tumor Progression through Regulating SP1 in Colorectal Cancer. | Cancers (Basel) | 2023 | 37173968 | PubTator, text mining | PubMed |
| A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2. | Hereditas | 2023 | 37170390 | PubTator, text mining | PubMed |
| Shining a LIGHT on myeloid cell targeted immunotherapy. | Eur J Cancer | 2023 | 37167762 | PubTator, text mining | PubMed |
| Influenza Virus-Induced Paracrine Cellular Senescence of the Lung Contributes to Enhanced Viral Load. | Aging Dis | 2023 | 37163429 | PubTator, text mining | PubMed |
| Adenylate kinase 2 is a biomarker related to the prognosis of glioma and the immune microenvironment. | J Clin Lab Anal | 2023 | 37161605 | PubTator, text mining | PubMed |
| Potential prognostic and immunotherapeutic value of calponin 1: A pan-cancer analysis. | Front Pharmacol | 2023 | 37153789 | PubTator, text mining | PubMed |
| Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells. | Front Oncol | 2023 | 37152024 | PubTator, text mining | PubMed |
| Comprehensive prediction of immune microenvironment and hot and cold tumor differentiation in cutaneous melanoma based on necroptosis-related lncRNA. | Sci Rep | 2023 | 37147395 | PubTator, text mining | PubMed |
| A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer. | Medicine (Baltimore) | 2023 | 37145007 | PubTator, text mining | PubMed |
| Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion. | Front Immunol | 2023 | 37143656 | PubTator, text mining | PubMed |
| Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma. | J Bone Oncol | 2023 | 37139222 | PubTator, text mining | PubMed |
| Membrane fusion, potential threats, and natural antiviral drugs of pseudorabies virus. | Vet Res | 2023 | 37131259 | PubTator, text mining | PubMed |
| Single-cell landscape analysis unravels molecular programming of the human B cell compartment in chronic GVHD. | JCI Insight | 2023 | 37129971 | PubTator, text mining | PubMed |
| GPR176 Is a Biomarker for Predicting Prognosis and Immune Infiltration in Stomach Adenocarcinoma. | Mediators Inflamm | 2023 | 37124060 | PubTator, text mining | PubMed |
| Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma. | World J Gastrointest Oncol | 2023 | 37123057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=30